These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37923879)

  • 1. Response to letter by Alain Braillon.
    Giesbrecht N; Hobin E; Price T; Stockwell T; Vallance K; Wettlaufer A
    Can J Public Health; 2023 Dec; 114(6):981-982. PubMed ID: 37923879
    [No Abstract]   [Full Text] [Related]  

  • 2. [Response to letter to the editor of Dr. Braillon Alain Granger and Professor Bernard about the publication "Benefits of reducing alcohol consumption: How to do it with nalmefene"].
    Bendimerad P; Blecha L
    Encephale; 2015 Sep; 41(4):380-1. PubMed ID: 26341539
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to "Trials for depressive disorder in adolescents: the emperor's new clothes," a letter to the editor by Alain Braillon, MD, PhD.
    Butcher NJ; Mew EJ; Monsour A; Szatmari P; Monga S; Offringa M;
    J Clin Epidemiol; 2020 Dec; 128():159-161. PubMed ID: 32860976
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to Dr. Alain Braillon.
    van Meenen LC; van Meenen DM; de Rooij SE; ter Riet G
    J Am Geriatr Soc; 2015 Jun; 63(6):1282-3. PubMed ID: 26096425
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to Dr Alain Braillon.
    La Placa V; Knight A
    Public Health; 2014 Jul; 128(7):679. PubMed ID: 25065522
    [No Abstract]   [Full Text] [Related]  

  • 6. Wim van den Brink and colleagues reply to Des Spence and Alain Braillon.
    van den Brink W; Mann K; Gual A; Aubin HJ
    BMJ; 2014 Apr; 348():g2605. PubMed ID: 24711667
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter by Braillon Regarding Article, "Resource Effective Strategies to Prevent and Treat Cardiovascular Disease".
    Braillon A
    Circulation; 2016 Aug; 134(7):e85-6. PubMed ID: 27528652
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter by Braillon and Marron Regarding "Mind-Body Interventions, Psychological Stressors, and Quality of Life in Stroke Survivors".
    Braillon A; Marron L
    Stroke; 2019 May; 50(5):e143. PubMed ID: 30935316
    [No Abstract]   [Full Text] [Related]  

  • 9. On the importance of promoting graduate funding opportunities: A response to CIHR President Alain Beaudet's open letter.
    Gagné T; Lapalme J
    Can J Public Health; 2016 Aug; 107(2):e218. PubMed ID: 27526226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter by Braillon Regarding Article, "Contribution of Established Stroke Risk Factors to the Burden of Stroke in Young Adults".
    Braillon A
    Stroke; 2017 Oct; 48(10):e315. PubMed ID: 28887394
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter by Braillon Regarding Article, "Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting".
    Braillon A
    Circulation; 2017 Nov; 136(22):2204-2205. PubMed ID: 29180501
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to the letter to the editor 'Surrogate end points for overall survival. Festina lente (more haste, less speed)' by Braillon.
    Maeda H; Kurokawa T
    Ann Oncol; 2015 Apr; 26(4):818-819. PubMed ID: 25595935
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter by Braillon Regarding Article, "Very High Coronary Artery Calcium (≥1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA".
    Braillon A
    Circulation; 2021 Oct; 144(17):e274. PubMed ID: 34694895
    [No Abstract]   [Full Text] [Related]  

  • 14. Answer to letter: Factors that can alter the melatonin circadian rhythm, by Yvan Touitou, Michael H. Smolensky and Alain Reinberg.
    Wieczorek J; Blazejczyk K; Morita T
    Chronobiol Int; 2016; 33(9):1131-1135. PubMed ID: 27715323
    [No Abstract]   [Full Text] [Related]  

  • 15. An open letter to Alain Enthoven.
    Yarmolinsky A
    Health Aff (Millwood); 1997; 16(4):280-4. PubMed ID: 9248173
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Francesco Massari, Vincenzo Di Nunno, and Andrea Ardizzoni's Letter to the Editor re: Robert J. Motzer, Alain Ravaud, Jean-Jacques Patard, et al. Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results. Eur Urol 2018;73:62-8.
    Motzer RJ; Escudier B; Ravaud A
    Eur Urol; 2018 Mar; 73(3):e73. PubMed ID: 29126652
    [No Abstract]   [Full Text] [Related]  

  • 17. A Point-by-Point Response to Braillon.
    Rolland B; Paille F; Gillet C; Rigaud A; Moirand R; Dano C; Dematteis M; Mann K; Aubin HJ
    CNS Neurosci Ther; 2016 Jun; 22(6):537-8. PubMed ID: 27177736
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to Dr Braillon.
    Mueller S
    Alcohol Alcohol; 2020 Apr; 55(3):338. PubMed ID: 32166325
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to Dr Braillon.
    Feldman A; Datz C; Aigner E
    Am J Gastroenterol; 2017 Mar; 112(3):512. PubMed ID: 28270666
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to Braillon.
    Bonanni B; Serrano D; Maisonneuve P; Lazzeroni M; Brown PH; Guerrieri-Gonzaga A; Szabo E
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33556158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.